We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines, and consumer healthcare.

  • Pharmaceuticals: Our medicines treat a range of conditions including respiratory, Hepatitis B, neurological disorders (depression, anxiety, epilepsy), deep vein thrombosis, heart disease, and HIV/AIDS
  • Consumer Healthcare: We are one of the world's largest consumer healthcare companies, dedicated to everyday healthcare. Our consumer healthcare products address everyday conditions within our categories of Total Wellness, Skin Health, Oral Care and Nutrition. Our portfolio includes well-known brands such as: Contac, Fenbid, Bactroban and Sensodyne.
  • Vaccines: We are the world's leading global vaccines supplier. Our vaccines for children and adults help to prevent illness by protecting against infectious diseases, including Engerix B for the prevention of Hepatitis B, Vaxem HIB for Haemophilus influenzae type b, Yuganning for seasonal flu, and Yunaoning for meningitis.

In March 2015 we completed a 3-part transaction with Novartis which reshapes our business. We acquired Novartis's vaccines business (including the influenza vaccines in China only) and combined our Consumer Healthcare businesses to create a new company. In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it.

Learn more  on about our products that help people do more, feel better, and live longer.